ChromaDex CEO: ‘Purchasing practices need to change to fix quality standards’

Frank Jaksch, CEO and co-founder of ChromaDex

Concerns about quality standards in the dietary supplements industry are not due to analytical testing, but due to poor supply chain management, says Frank Jaksch, CEO and co-founder of ChromaDex.

“We still see the same issues [regarding quality], and these things are still lingering even with everything the industry has experienced over the last couple of years,” Jaksch told us, referring to the extensive changes the industry has undergone since the New York Attorney General launched his probe into herbal supplements in February 2015.

“It’s still the basics,” he added. “It’s a failure to set specifications; a failure to perform basic identity testing; a failure to do appropriate testing. This is more widespread than you’d think.

Jaksch continued: “Analytical methods get pointed at a lot, but they have nothing to do with the problem. The problem is everything else. Analytical testing is used as the scapegoat.

Solution is outside the lab

Jaksch explained that the key to solving problems with analytical testing lies outside of the laboratory. 

“Analytical testing is something a company should do to confirm what they should already know through sound supply chain management practices,” he said. “Qualification, audit, inspection and approval of suppliers or vendors is a key part of an appropriate supply chain management plan. 

“Selection and approval of appropriate analytical testing methods is a critical part of vendor qualification, however it is often overlooked as a part of the process.

“Business practices, and especially purchasing practices within the industry, need to change, and if they do not change, analytical testing will continue to be the whipping post for years to come.”

ICSB

Jaksch will speak at length about this subject at the upcoming 17th Annual Oxford International Conference on the Science of Botanicals in Oxford, Mississippi (April 3-6, 2017). For more information and to register for this event, please click HERE.

“I have two main goals for the presentation,” he said. “First, to point the area where the problem lies. Although there may be a lot of arguing over analytic methods and which is best, the problem lies elsewhere. And second, I will point out what good practices should really look like.”

Related News

© iStock/wellesenterprises

Regulations, supply chain, and deep science take center stage in Oxford

Rick Kingston, PharmD, led a town hall session at the recent botanicals science conference in Oxford, MS. NutraIngredients-USA photo.

Panel: Consumers don't understand much about quality

Is DNA barcoding now the adulteration tool du jour?

Is DNA barcoding now the adulteration tool du jour?

‘Game changer’: ChromaDex inks deal with Suntava to produce concentrated anthocyanin ingredient

‘Game changer’: ChromaDex inks deal with Suntava to produce concentrated anthocyanin ingredient

Transparency could be the 1st step towards greater consistency in testing methods & labs: Experts

Transparency could be the 1st step towards greater consistency in testing methods & labs: Experts

“A qualified list has to be based on laboratory proficiency and capabilities and specific to the type of analysis the lab is proficient in” - Ed Wyszumiala, president of Wysz Consulting Solutions

‘Dry labbing’ is still out there, and there is still a market for it, say analytical experts

Chromadex CEO: 'If we need to spend millions of dollars to develop an ingredient pipeline, we will do that'

Chromadex CEO: 'If we need to spend millions of dollars to develop an ingredient pipeline, we will do that'

“Determining the proper identity, authenticity, and lack of adulteration of all botanical materials that are known to be adulterated is an important part of maintaining proper GMPs” - Mark Blumenthal, ABC.

Experts outline 7 seven basic tips for selecting a contract laboratory: HerbalGram article

Related Products

See more related products